Martin Lukas
4PUBLICATIONS
9CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (4)
Sort by Publication Date:
|Mar 02, 2022
A switch from originator-adalimumab to the biosimilar SB5 in patients with Crohn's disease: an analysis of two propensity score-matched cohorts.M Lukas, M Kolar, J Reissigova
|Oct 03, 2018
Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort.Anita Bálint, Mariann Rutka, Martin Kolar
Pageof 1

